Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Doerig

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Antimicrobial Agents and Chemotherapy|November 16, 2001
In vitro activities of two antimitotic compounds, pancratistatin and 7-deoxynarciclasine, against Encephalitozoon intestinalis, a microsporidium causing infections in humansM Ouarzane-Amara, J F Franetich, D Mazier, et al.
The Journal of Eukaryotic Microbiology|March 22, 2002
In vitro activity of antimitotic compounds against the microsporidium Encephalitozoon intestinalisM O Amara, J F Franetich, N Bouladoux, et al.
Biochemical and Biophysical Research Communications|November 9, 2001
Influence of human p16(INK4) and p21(CIP1) on the in vitro activity of recombinant Plasmodium falciparum cyclin-dependent protein kinasesZ Li, K Le Roch, J A Geyer, et al.
European Journal of Biochemistry|September 18, 2001
The H89 cAMP-dependent protein kinase inhibitor blocks Plasmodium falciparum development in infected erythrocytesC Syin, D Parzy, F Traincard, et al.
Chemistry & Biology|June 30, 2000
Intracellular targets of cyclin-dependent kinase inhibitors: identification by affinity chromatography using immobilised inhibitorsM Knockaert, N Gray, E Damiens, et al.
Bioorganic & Medicinal Chemistry|March 7, 2024
Target fishing reveals PfPYK-1 and PfRab6 as potential targets of an antiplasmodial 4-anilino-2-trichloromethylquinazoline hit compoundC Kieffer, N Primas, S Hutter, et al.
Parasite (Paris, France)|October 21, 2009
Signalling in malaria parasites. The MALSIG consortiumC Doerig, D Baker, O Billker, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Antimicrobial Agents and Chemotherapy|November 16, 2001
In vitro activities of two antimitotic compounds, pancratistatin and 7-deoxynarciclasine, against Encephalitozoon intestinalis, a microsporidium causing infections in humansM Ouarzane-Amara, J F Franetich, D Mazier, et al.
The Journal of Eukaryotic Microbiology|March 22, 2002
In vitro activity of antimitotic compounds against the microsporidium Encephalitozoon intestinalisM O Amara, J F Franetich, N Bouladoux, et al.
Biochemical and Biophysical Research Communications|November 9, 2001
Influence of human p16(INK4) and p21(CIP1) on the in vitro activity of recombinant Plasmodium falciparum cyclin-dependent protein kinasesZ Li, K Le Roch, J A Geyer, et al.
European Journal of Biochemistry|September 18, 2001
The H89 cAMP-dependent protein kinase inhibitor blocks Plasmodium falciparum development in infected erythrocytesC Syin, D Parzy, F Traincard, et al.
Chemistry & Biology|June 30, 2000
Intracellular targets of cyclin-dependent kinase inhibitors: identification by affinity chromatography using immobilised inhibitorsM Knockaert, N Gray, E Damiens, et al.
Bioorganic & Medicinal Chemistry|March 7, 2024
Target fishing reveals PfPYK-1 and PfRab6 as potential targets of an antiplasmodial 4-anilino-2-trichloromethylquinazoline hit compoundC Kieffer, N Primas, S Hutter, et al.
Parasite (Paris, France)|October 21, 2009
Signalling in malaria parasites. The MALSIG consortiumC Doerig, D Baker, O Billker, et al.
Pageof 4